昆虫学报 ›› 2025, Vol. 68 ›› Issue (9): 1242-1250.doi: 10.16380/j.kcxb.2025.09.008

• 研究论文 • 上一篇    下一篇

SPINK7识别和聚集细菌启动家蚕血细胞介导的抗细菌感染免疫防御

安玲娜1,2,#, 李卓俞2,#, 张艳2, 郭鹏超2, 郭凯雨2刘文月2, 董照明2, 赵萍2,*   

  1. (1. 陆军军医大学(第三军医大学)第二附属医院血液病医学中心, 重庆 400038; 2. 西南大学前沿交叉学科研究院生物学研究中心, 重庆 400715)
  • 出版日期:2024-09-20 发布日期:2025-10-28

SPINK7 recognizes and aggregates bacteria to initiate Bombyx mori blood cells-mediated immune defenses against bacterial infections

AN Ling-Na1,2,#, LI Zhuo-Yu2,#, ZHANG Yan2, GUO Peng-Chao2, GUO Kai-Yu2, LIU Wen-Yue2, DONG Zhao-Ming2, ZHAO Ping2,*   

  1. (1. Hematology Medical Center, Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing 400038, China; 2. Biological Science Research Center, Academy for Advanced Interdisciplinary Studies, Southwest University, Chongqing 400715, China)
  • Online:2024-09-20 Published:2025-10-28

摘要: 【目的】阐明Kazal型丝氨酸蛋白酶抑制剂7(serine protease inhibitor Kazal-type 7, SPINK7)的生物学功能及其在家蚕Bombyx mori抵抗细菌侵染中的免疫识别机制。【方法】对家蚕SPINK7蛋白进行生物信息学分析和原核表达;利用圆二色谱分析SPINK7的二级结构及其耐热性;利用非还原性电泳及Western blot检测SPINK7的聚体形成趋势;利用大肠杆菌Escherichia coli和金黄色葡萄球菌Staphylococcus aureus分别侵染家蚕5龄幼虫,利用qPCR和Western blot分别检测SPINK7基因在血细胞和脂肪体中的表达量及SPINK7在血清中的蛋白含量;通过细菌抑制曲线分析SPINK7对大肠杆菌、金黄色葡萄球菌和藤黄微球菌Micrococcus luteus的抑菌活性;通过免疫荧光定位和酶联免疫吸附试验(enzyme-linked immunosorbent assay, ELISA)方法检测SPINK7与肽聚糖和脂多糖等病原体相关分子模式(pathogen associated molecular patterns, PAMPs)的结合,以及SPINK7与大肠杆菌、金黄色葡萄球菌和藤黄微球菌的结合。【结果】SPINK7由3个保守的Kazal结构域组成,各结构域含有6个半胱氨酸,分别形成3对二硫键;二级结构主要为α螺旋结构,与Kazal结构域典型二级结构一致,耐热性好,且在80 ℃时结构依然较为稳定。大肠杆菌和金黄色葡萄球菌诱导后,SPINK7会形成多聚体结构,并在家蚕5龄幼虫的血细胞和脂肪体中的表达量以及在血清中的蛋白含量均比磷酸缓冲液(PBS)对照组发生显著上调。SPINK7并非直接抑制细菌活性,而是通过与细菌PAMPs结合并促使细菌聚集。【结论】SPINK7是一种Kazal型的免疫相关蛋白,其在家蚕受到细菌侵染后表达上调并形成多聚体,通过识别并结合细菌PAMPs帮助家蚕血细胞聚集细菌并发挥免疫效应。

关键词: 家蚕, 病原体相关分子模式, Kazal型丝氨酸蛋白酶抑制剂7, 细胞免疫, 吞噬作用

Abstract: 【Aim】 To elucidate the biological function of serine protease inhibitor Kazal-type 7 (SPINK7) and its immunorecognition mechanism of Bombyx mori against bacterial infestation. 【Methods】 Bioinformatics analysis of SPINK7 of B. mori was made followed by prokaryotic expression, and the secondary structure and heat resistance of SPINK7 were analyzed by circular dichroism. The tendency of SPINK7 to form aggregates was detected by non-reducing electrophoresis and Western blot. The 5th instar larvae of B. mori were infected by Escherichia coli and Staphylococcus aureus, respectively, and the expression levels of SPINK7 gene in hemocytes and fat bodies were detected by qPCR, and the SPINK7 content in serum was detected by Western blot. The inhibitory activities of SPINK7 against E. coli, S. aureus and Micrococcus luteus were analyzed by bacterial inhibition curves. The binding of SPINK7 to pathogen-associated molecular patterns (PAMPs) such as peptidoglycan and lipopolysaccharide, and the binding of SPINK7 to E. coli, S. aureus and M. luteus were detected by immunofluorescence localization and enzyme-linked immunosorbent assay (ELISA).【Results】 SPINK7 consists of three conserved Kazal structural domains, each of which contains six cysteines, forming three pairs of disulfide bonds. The secondary structure of SPINK7 is mainly α-helix, which is consistent with the typical secondary structure of Kazal structural domains, it is heat-resisting and remains structurally stable at 80 ℃. After induction by E. coli and S. aureus, SPINK7 formed a multimeric structure, and the expression levels of SPINK7 gene in hemocytes and fat bodies and the SPINK7 content in the serum of the 5th instar larvae of B. mori were significantly up-regulated, as compared with those of the phosphate buffer solution (PBS) control group. SPINK7 did not directly inhibit bacterial activity, and promoted bacterial aggregation by binding to bacterial PAMPs. 【Conclusion】SPINK7 is a Kazal-type immune-associated protein, whose expression is up-regulated and multimerized after bacterial infestation in B. mori, and helps hemocytes to aggregate bacteria and exert immune effect by recognizing and binding to bacterial PAMPs.

Key words: Bombyx mori, pathogen-associated molecular patterns, serine protease inhibitor Kazal-type 7, cellular immunity, phagocytosis